Friday, March 27, 2020

GlaxoSmith Regulatory Specialist MSR Coordination Senior


GlaxoSmith Regulatory Specialist MSR Coordination Senior


Key Responsibilities:

Minimum 5 years of experience in CMC variation in all the markets

Expertise in CMC Authoring of Variation dossier (focus on Module 3 components authoring)
Experience in authoring variation of Vaccines (preferable) , we can consider for Pharma also
CMC Variation experience for – EU and ROW / International markets

Knowledge on Vaccines

With minimal input from manager executes agreed dossier strategy

manages multiple project assignments (e.g., Variations <CMC & Therapeutic>, Product Expansion dossiers, Renewals, MSRs <CMC&non-CMC>) simultaneously; dossiers will range in complexity

completes data assessment to ensure dossier is fit for purpose.

identifies risks associated with submission data and information packages.

Communicates with line manager to identify issues that have business impact.

May have dossier review responsibilities for peers and may identify improvement opportunities for Regulatory processes, policies and systems.

Developing an understanding of regulations, guidelines, procedures and policies relating to registration and manufacturing of pharmaceutical products, to expedite submission, review and approval of global regulatory applications.

Understands internal/external Regulatory environment.

Actively builds an organizational network.

Communicates across GSK, with minimal input from manager regarding project and policy issues ensuring optimum position for GSK.

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. We believe that we all bring something unique to GSK and when we combine our knowledge, experiences and styles together, the impact is incredible. Come join our adventure at GSK where you will be inspired to do your best work for our patients and consumers. A place where you can be you, feel good and keep growing.

TO APPLY CLICK HERE

FOR MORE JOB UPDATES




JOIN IN GROUP FOR DAILY UPDATES


No comments:

Post a Comment